Delivery Order SPE2DR25D3505-SPE2DR26F01BC
Award Date 3/31/26
Potential Completion Date 4/1/26
Potential Value $2.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency issued a $4,646.94 delivery order to Amerisourcebergen Drug Corp on March 30, 2026, for moxifloxacin HCL 400 mg tablet UD 50s, with ultimate completion on March 31, 2026.</p> <p>The order is issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical valued at $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.</p>
- <p>The Defense Logistics Agency issued a $40,204.60 delivery order to Amerisourcebergen Drug Corp on March 12, 2026, for moxifloxacin HCl 400 mg tablet unit dose packs of 50 tablets.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. The order carries firm fixed pricing with an ultimate completion date of March 13, 2026.</p>
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 25, 2026, for moxifloxacin HCL 400 mg tablets (30-count), with a ceiling value of $1,198.16.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of February 26, 2026. No set-aside was used.</p>
- The Defense Logistics Agency's Medical Supply Chain issued a $1,495.40 delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for moxifloxacin HCL 400 mg tablet UD 50s, with ultimate completion on June 23, 2025. The order is issued under the SPE2DX Indefinite Delivery Contract, a $999,999,999 global pharmaceutical support vehicle running through December 2026 that enables supply of pharmaceutical products and medical supplies to military healthcare programs worldwide. Pricing is firm...
- The Defense Logistics Agency awarded a $1,364.93 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Moxifloxacin HCL 400 mg tablets (30-count packages). The contract utilizes a firm fixed-price delivery order structure with an ultimate completion date of September 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement, indicating it was awarded through open competition....
- <p>The Defense Logistics Agency issued a $23,590.02 delivery order to Amerisourcebergen Drug Corp on March 20, 2026, for moxifloxacin HCl 400 mg tablets under firm fixed-price terms with an ultimate completion date of March 23, 2026.</p> <p>Place of performance is Conshohocken, PA. The order carries no set-aside designation and was issued competitively.</p>
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Moxifloxacin HCL 400 mg tablets (30-count packages) with a contract ceiling value of $1,188.24. This competitively awarded, non-set-aside delivery order carries a firm fixed price and is scheduled for completion by September 15, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for moxifloxacin hydrochloride 400 mg tablets in unit dose packaging of 50s, with a ceiling value of $2,070.00. Awarded on August 14, 2025, this firm fixed-price delivery order is due for completion by August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, consistent with...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Moxifloxacin HCl 400 mg tablets (30-count packaging) with a ceiling value of $1,596.49. This firm fixed-price delivery order is set to be completed by August 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded without set-aside designation through competitive...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for moxifloxacin HCl 400 mg tablets (unit dose, 50s) with a ceiling value of $1,380.00. This competitive, non-set-aside contract was awarded on July 31, 2025, with a completion date of August 1, 2025. The order will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, under firm fixed-price terms as a delivery order, indicating this is a fulfillment against an...
- SPE2DR25D3505Indefinite Delivery Contract
- SPE2DR25D3505-SPE2DR26F01BCDelivery Order
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 31, 2026, for moxifloxacin HCl 400 mg tablets (30-count), with a ceiling value of $2,114.40, under a firm fixed-price structure and no set-aside category. Place of performance is Conshohocken, PA. The order completes April 1, 2026. This delivery order executes against the parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026, which enables supply of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 6/30/26, 10:51 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 3/30/26 |